<DOC>
	<DOCNO>NCT01826981</DOCNO>
	<brief_summary>The purpose study evaluate antiviral efficacy , safety , tolerability combination therapy sofosbuvir ( SOF ) contain regimens treatment chronic hepatitis C virus ( HCV ) infection .</brief_summary>
	<brief_title>Efficacy Safety Sofosbuvir Containing Regimens Treatment Chronic HCV Infection Participants With Chronic Genotype 1 , 2 , 3 , 6 HCV Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Chronic genotype 1 , 2 , 3 , 6 HCV infection Cirrhosis determination ; liver biopsy may require Screening laboratory value within define threshold Use two effective contraception method female childbearing potential sexually active male Pregnant nursing female male pregnant female partner Hepatocellular carcinoma ( HCC ) malignancy ( exception certain resolve skin cancer ) Chronic use systemic immunosuppressive agent History clinically significant illness medical disorder may interfere individual 's treatment , assessment compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>